Abeona Therapeutics (ABEO) Institutional Ownership $6.95 +0.10 (+1.46%) Closing price 04:00 PM EasternExtended Trading$6.96 +0.00 (+0.07%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Abeona Therapeutics (NASDAQ:ABEO)CurrentInstitutional OwnershipPercentage80.56%Number ofInstitutional Buyers(last 12 months)49TotalInstitutional Inflows(last 12 months)$47.20MNumber ofInstitutional Sellers(last 12 months)15TotalInstitutional Outflows(last 12 months)$27.31M Get ABEO Insider Trade Alerts Want to know when executives and insiders are buying or selling Abeona Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ABEO Institutional Buying and Selling by Quarter Abeona Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/27/2025 Squarepoint Ops LLC141,978$806K0.0%+274.2%0.277% 8/15/2025 Corient Private Wealth LLC22,416$127K0.0%N/A0.044% 8/15/2025 Man Group plc11,794$67K0.0%N/A0.023% 8/15/2025 BNP Paribas Financial Markets131,945$749K0.0%N/A0.258% 8/15/2025 Boone Capital Management LLC1,254,658$7.13M3.1%N/A2.452% 8/15/2025 Boothbay Fund Management LLC20,586$117K0.0%-90.6%0.040% 8/15/2025 Bank of America Corp DE329,884$1.87M0.0%+154.9%0.645% 8/15/2025 683 Capital Management LLC750,000$4.26M0.3%+11.1%1.466% 8/15/2025 Adage Capital Partners GP L.L.C.3,072,985$17.46M0.0%+14.2%6.007% 8/15/2025 AWM Investment Company Inc.470,000$2.67M0.3%N/A0.919% Get the Latest News and Ratings for ABEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abeona Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.23,906$136K0.0%N/A0.047% 8/14/2025 The Manufacturers Life Insurance Company 16,913$96K0.0%N/A0.033% 8/14/2025 Squarepoint Ops LLC141,978$806K0.0%+274.2%0.278% 8/14/2025 Qube Research & Technologies Ltd33,793$192K0.0%-66.3%0.066% 8/14/2025 Bollard Group LLC49,393$281K0.0%N/A0.097% 8/13/2025 Diametric Capital LP138,363$786K0.4%+637.8%0.270% 8/13/2025 Marshall Wace LLP85,124$484K0.0%-74.4%0.166% 8/13/2025 Stonepine Capital Management LLC45,000$256K0.3%N/A0.088% 8/13/2025 Kennedy Capital Management LLC672,003$3.82M0.1%+8.1%1.314% 8/13/2025 Invesco Ltd.22,915$130K0.0%N/A0.045% 8/13/2025 New York State Common Retirement Fund17,000$97K0.0%N/A0.033% 8/12/2025 Ameritas Investment Partners Inc.4,459$25K0.0%N/A0.009% 8/12/2025 Rhumbline Advisers67,505$383K0.0%+3,541.0%0.132% 8/12/2025 Legal & General Group Plc4,815$27K0.0%N/A0.009% 8/12/2025 JPMorgan Chase & Co.831,132$4.72M0.0%+255.6%1.625% 8/8/2025 Intech Investment Management LLC21,049$120K0.0%N/A0.041% 8/8/2025 Creative Planning14,310$81K0.0%+43.0%0.028% 8/8/2025 Police & Firemen s Retirement System of New Jersey11,005$63K0.0%N/A0.022% 8/8/2025 Geode Capital Management LLC1,105,862$6.28M0.0%+129.1%2.162% 8/8/2025 Nan Fung Trinity HK Ltd.560,770$3.19M0.4%N/A1.096% 8/7/2025 Simplify Asset Management Inc.558,584$3.17M0.2%+36.7%1.092% 8/7/2025 Los Angeles Capital Management LLC268,148$1.52M0.0%N/A0.524% 8/1/2025 Y Intercept Hong Kong Ltd102,336$581K0.0%N/A0.200% 8/1/2025 Riverwater Partners LLC10,894$62K0.0%N/A0.021% 6/27/2025 Goldman Sachs Group Inc.200,450$954K0.0%+49.6%0.392% 5/19/2025 Jane Street Group LLC128,919$614K0.0%-1.9%0.264% 5/16/2025 Goldman Sachs Group Inc.200,450$954K0.0%+49.6%0.411% 5/16/2025 Newtyn Management LLC480,000$2.29M0.4%+26.3%0.984% 5/16/2025 Millennium Management LLC809,966$3.86M0.0%-61.7%1.660% 5/16/2025 683 Capital Management LLC675,000$3.21M0.2%-14.8%1.383% What's the Best Way to Lower RMD Taxes? (Ad)Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.Click here to see the six strategies and get your free advisor matches today.5/16/2025 Adage Capital Partners GP L.L.C.2,691,628$12.81M0.0%-31.0%5.516% 5/15/2025 Trexquant Investment LP119,274$568K0.0%+74.1%0.244% 5/15/2025 OMERS ADMINISTRATION Corp72,200$344K0.0%+11.0%0.148% 5/14/2025 Walleye Capital LLC183,306$873K0.0%-68.7%0.376% 5/14/2025 Wellington Management Group LLP153,121$729K0.0%+64.1%0.314% 4/28/2025 Cannon Global Investment Management LLC14,000$67K0.1%N/A0.029% 3/24/2025 Wellington Management Group LLP93,289$520K0.0%N/A0.215% 2/17/2025 Western Standard LLC2,084,418$11.61M7.7%+22.8%4.795% 2/17/2025 Squarepoint Ops LLC12,028$67K0.0%N/A0.028% 2/17/2025 Twinbeech Capital LP10,425$58K0.0%N/A0.024% 2/17/2025 OMERS ADMINISTRATION Corp65,045$362K0.0%N/A0.150% 2/17/2025 Millennium Management LLC2,117,169$11.79M0.0%-8.0%4.870% 2/17/2025 Balyasny Asset Management L.P.34,128$190K0.0%N/A0.079% 2/17/2025 Bank of America Corp DE264,439$1.47M0.0%+16.7%0.608% 2/17/2025 683 Capital Management LLC791,845$4.41M0.3%+17.3%1.822% 2/14/2025 Jane Street Group LLC131,478$732K0.0%+894.8%0.302% 2/14/2025 Schonfeld Strategic Advisors LLC61,266$341K0.0%N/A0.141% 2/14/2025 Northern Trust Corp184,929$1.03M0.0%+6.6%0.425% 2/14/2025 Oxford Asset Management LLP21,121$118K0.1%N/A0.049% 2/14/2025 Adage Capital Partners GP L.L.C.3,902,360$21.74M0.0%+20.1%8.977% 2/13/2025 Marshall Wace LLP51,328$286K0.0%-39.0%0.118% 2/13/2025 Walleye Capital LLC586,250$3.27M0.0%-31.9%1.349% 2/13/2025 Renaissance Technologies LLC89,237$497K0.0%-33.5%0.205% 2/12/2025 Trexquant Investment LP68,516$382K0.0%N/A0.158% 2/12/2025 Wellington Management Group LLP93,289$520K0.0%N/A0.215% 2/11/2025 Rosalind Advisors Inc.1,805,390$10.06M5.0%-1.5%4.153% 1/24/2025 abrdn plc224,356$1.25M0.0%-31.4%0.516% 12/26/2024 JPMorgan Chase & Co.67,138$424K0.0%+74.2%0.154% 11/19/2024 Barclays PLC55,000$348K0.0%-28.0%0.127% 11/16/2024 Geode Capital Management LLC465,317$2.94M0.0%+21.7%1.074% 11/15/2024 Barclays PLC55,000$348K0.0%-28.0%0.127% 11/15/2024 XTX Topco Ltd25,301$160K0.0%N/A0.058% 11/15/2024 Jane Street Group LLC13,216$84K0.0%N/A0.031% 11/15/2024 Western Standard LLC1,698,097$10.73M10.1%+7.0%3.921% 11/15/2024 State Street Corp159,295$1.01M0.0%-1.6%0.368% 11/15/2024 Ikarian Capital LLC583,593$3.69M0.5%-24.1%1.347% 11/14/2024 Walleye Capital LLC861,301$5.44M0.0%-13.0%1.989% 11/13/2024 Propel Bio Management LLC624,022$3.94M2.3%-50.0%1.441% 11/12/2024 Citigroup Inc.616,668$3.90M0.0%+10.1%1.424% 11/12/2024 Charles Schwab Investment Management Inc.23,850$151K0.0%N/A0.055% 11/5/2024 GSA Capital Partners LLP96,092$607K0.0%+54.3%0.222% 10/30/2024 Rosalind Advisors Inc.1,832,000$11.58M7.3%+4.7%4.472% 10/25/2024 abrdn plc326,995$2.07M0.0%+158.8%0.798% 8/13/2024 Simplify Asset Management Inc.408,584$1.73M0.1%N/A0.997% 8/9/2024 Renaissance Technologies LLC503,293$2.13M0.0%+581.6%1.229% 7/26/2024 Bank of New York Mellon Corp121,453$515K0.0%+2.0%0.297% 7/12/2024 Rosalind Advisors Inc.1,750,000$7.42M5.4%N/A4.272% 5/17/2024 Western Standard LLC1,361,489$9.87M4.7%+68.5%4.978% 5/10/2024 Acadian Asset Management LLC12,634$91K0.0%N/A0.046% 2/12/2024 AIGH Capital Management LLC787,769$3.95M1.6%-30.6%3.180% The Orphaned Well Crisis Hidden Across America (Ad)Across the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dangerous problem hiding under farmland, neighborhoods, and even city streets. One little-known company is tackling this head-on. Its crews seal old wells, prevent further leaks, and generate revenue not just from contracts, but also from selling verified carbon credits tied to methane abatement. With federal funding already committed and state budgets on the rise, the opportunity here is enormous.Read the full story here2/9/2024 Worth Venture Partners LLC196,439$984K0.5%-30.2%0.793% 2/7/2024 Jump Financial LLC39,757$199K0.0%N/A0.160% 11/15/2023 Worth Venture Partners LLC281,280$1.18M0.7%+76.6%1.136% 11/15/2023 Adage Capital Partners GP L.L.C.3,249,994$13.68M0.0%+84.5%13.126% 11/14/2023 Schonfeld Strategic Advisors LLC153,930$648K0.0%N/A0.622% 11/13/2023 AIGH Capital Management LLC1,135,252$4.78M2.3%+77.7%4.585% 11/9/2023 Citigroup Inc.450,000$1.89M0.0%+125.0%1.817% 11/7/2023 Barclays PLC371,276$1.56M0.0%+100.0%1.499% 11/1/2023 Simplex Trading LLC14,128$59K0.0%+1,889.9%0.057% 7/27/2023 Virtu Financial LLC32,171$130K0.0%N/A0.171% (Data available from 1/1/2016 forward) ABEO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ABEO shares? During the previous two years, 65 institutional investors and hedge funds held shares of Abeona Therapeutics. The most heavily invested institutionals were Adage Capital Partners GP L.L.C. ($17.46M), Western Standard LLC ($11.61M), Rosalind Advisors Inc. ($10.06M), Boone Capital Management LLC ($7.13M), Geode Capital Management LLC ($6.28M), JPMorgan Chase & Co. ($4.72M), and 683 Capital Management LLC ($4.26M).Learn more on Abeona Therapeutics' institutional investors. What percentage of Abeona Therapeutics' stock is owned by institutional investors? 80.56% of Abeona Therapeutics' stock is owned by institutional investors. Learn more on ABEO's institutional investor holdings. Which institutional investors have been buying Abeona Therapeutics' stock? Of the 57 institutional investors that purchased Abeona Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Adage Capital Partners GP L.L.C. ($2.52M), Rosalind Advisors Inc. ($1.83M), Boone Capital Management LLC ($1.25M), Western Standard LLC ($1.05M), Geode Capital Management LLC ($706.29K), JPMorgan Chase & Co. ($625.98K), and Nan Fung Trinity HK Ltd. ($560.77K). How much institutional buying is happening at Abeona Therapeutics? Institutional investors have bought a total of 8,329,310 shares in the last 24 months. This purchase volume represents approximately $47.20M in transactions. Which of Abeona Therapeutics' major shareholders have been selling company stock? Of the 15 institutional investors that sold Abeona Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.49M), Adage Capital Partners GP L.L.C. ($1.21M), Walleye Capital LLC ($807.08K), Propel Bio Management LLC ($624.02K), Marshall Wace LLP ($280.12K), Boothbay Fund Management LLC ($197.82K), and Ikarian Capital LLC ($185.17K). How much institutional selling is happening at Abeona Therapeutics? Institutional investors have sold a total of 5,202,037 shares in the last 24 months. This volume of shares sold represents approximately $27.31M in transactions. Related Companies Avadel Pharmaceuticals Major Shareholders Ardelyx Major Shareholders Janux Therapeutics Major Shareholders Harrow Major Shareholders Vera Therapeutics Major Shareholders Amphastar Pharmaceuticals Major Shareholders Syndax Pharmaceuticals Major Shareholders 89BIO Major Shareholders Cogent Biosciences Major Shareholders ARS Pharmaceuticals Major Shareholders This page (NASDAQ:ABEO) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.